XML 64 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of non-vested restricted share
Non-vested share units as of January 1, 2023   16,665 
Granted   
-
 
Vested   
-
 
Non-vested share units as of March 31, 2023   16,665 

 

Schedule of the stock option activity
   Number of
Shares
   Average
Exercise Price
per Share
   Aggregate
Intrinsic
Value*
   Weighted Average
Remaining
Contractual
Term in Years
 
                 
Outstanding at January 1, 2023       2,200,044   $1.96   $
-
    4.7 
Exercisable at January 1, 2023       
-
    
-
   $
-
    
-
 
                               
Granted       -    
-
    
-
    
-
 
Exercised       
-
    
-
    
-
    
-
 
Forfeited   -    -    
-
    - 
Outstanding at March 31, 2023   2,200,044   $1.96   $
-
    4.45 
Exercisable at March 31, 2023   549,958   $1.96   $
-
    4.45 

  

* The intrinsic value of the stock options at March 31, 2023 is the amount by which the market value of the Company’s common stock of $0.88 as of March 31, 2023 exceeds the exercise price of the option.